Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kenney, Richard T.
Sacks, David L.
Sypek, Joseph P.
Vilela, Luciano
Gam, Albert A.
and
Evans-Davis, Kamela
1999.
Protective Immunity Using Recombinant Human IL-12 and Alum as Adjuvants in a Primate Model of Cutaneous Leishmaniasis.
The Journal of Immunology,
Vol. 163,
Issue. 8,
p.
4481.
Minodier, P.
Faraut-Gambarelli, F.
Nicaise, C.
Gire, C.
Garnier, J.M.
and
Dumon, H.
2000.
La vaccination contre les leishmanioses.
Médecine et Maladies Infectieuses,
Vol. 30,
Issue. 3,
p.
141.
Khalil, EAG
Hassan, AMEl
Zijlstra, EE
Mukhtar, MM
Ghalib, HW
Musa, Breyma
Ibrahim, ME
Kamil, Areeg A
Elsheikh, M
Babiker, A
and
Modabber, F
2000.
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.
The Lancet,
Vol. 356,
Issue. 9241,
p.
1565.
Probst, R. J.
Wellde, B. T.
Lawyer, P. G.
Stiteler, J. S.
and
Rowton, E. D.
2001.
Rhesus monkey model for Leishmania major transmitted by Phlebotomus papatasi sandfly bites.
Medical and Veterinary Entomology,
Vol. 15,
Issue. 1,
p.
12.
Misra, Alka
Dube, Anuradha
Srivastava, Bindu
Sharma, Preeti
Srivastava, J.K
Katiyar, J.C
and
Naik, Sita
2001.
Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG.
Vaccine,
Vol. 19,
Issue. 25-26,
p.
3485.
Fragaki, Konstantina
Suffia, Isabelle
Ferrua, Bernard
Rousseau, Déborah
Le Fichoux, Yves
and
Kubar, Joanna
2001.
Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters.
Vaccine,
Vol. 19,
Issue. 13-14,
p.
1701.
Amaral, VF
Teva, A
Oliveira-Neto, MP
Silva, AJ
Pereira, MS
Cupolillo, E
Porrozzi, R
Coutinho, SG
Pirmez, C
Beverley, SM
and
Grimaldi Jr, G
2002.
Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease.
Memórias do Instituto Oswaldo Cruz,
Vol. 97,
Issue. 7,
p.
1041.
Kamil, A.A.
Khalil, E.A.G.
Musa, A.M.
Modabber, F.
Mukhtar, M.M.
Ibrahim, M.E.
Zijlstra, E.E.
Sacks, D.
Smith, P.G.
Zicker, F.
and
El-Hassan, A.M.
2003.
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
Transactions of the Royal Society of Tropical Medicine and Hygiene,
Vol. 97,
Issue. 3,
p.
365.
Misra, Alka
Dube, A.
and
Naik, S.
2004.
Immune responses in normal Indian langur monkeys (Presbytis entellus) – a primate model for visceral leishmaniasis.
Journal of Medical Primatology,
Vol. 33,
Issue. 2,
p.
65.
GARG, RAVENDRA
SINGH, NIRPENDRA
and
DUBE, ANURADHA
2004.
Intake of nutrient supplements affects multiplication ofLeishmania donovaniin hamsters.
Parasitology,
Vol. 129,
Issue. 6,
p.
685.
Garg, R
Gupta, S K
Tripathi, P
Naik, S
Sundar, S
and
Dube, A
2005.
Immunostimulatory cellular responses of curedLeishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate ofLeishmania donovani.
Clinical and Experimental Immunology,
Vol. 140,
Issue. 1,
p.
149.
Hailu, Asrat
Mudawi Musa, Ahmed
Royce, Catherine
and
Wasunna, Monique
2005.
Visceral Leishmaniasis: New Health Tools Are Needed.
PLoS Medicine,
Vol. 2,
Issue. 7,
p.
e211.
Porrozzi, R.
Pereira, M.S.
Teva, A.
Volpini, A.C.
Pinto, M.A.
Marchevsky, R.S.
Barbosa, A.A.
and
Grimaldi, G.
2006.
Leishmania infantum-induced primary and challenge infections in rhesus monkeys (Macaca mulatta): a primate model for visceral leishmaniasis.
Transactions of the Royal Society of Tropical Medicine and Hygiene,
Vol. 100,
Issue. 10,
p.
926.
Gupta, Swati
Dube, Anuradha
and
Vyas, Suresh P.
2007.
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.
Journal of Drug Targeting,
Vol. 15,
Issue. 6,
p.
437.
Grimaldi Jr, Gabriel
2008.
The utility of rhesus monkey (Macaca mulatta) and other non-human primate models for preclinical testing of Leishmania candidate vaccines.
Memórias do Instituto Oswaldo Cruz,
Vol. 103,
Issue. 7,
p.
629.
Kumari, Shraddha
Samant, Mukesh
Misra, Pragya
Khare, Prashant
Sisodia, Brijesh
Shasany, Ajit K.
and
Dube, Anuradha
2008.
Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa offers long-lasting protection against experimental visceral leishmaniasis.
Vaccine,
Vol. 26,
Issue. 45,
p.
5700.
Samant, Mukesh
Gupta, Reema
Kumari, Shraddha
Misra, Pragya
Khare, Prashant
Kushawaha, Pramod Kumar
Sahasrabuddhe, Amogh Anant
and
Dube, Anuradha
2009.
Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis.
The Journal of Immunology,
Vol. 183,
Issue. 1,
p.
470.
Nagill, Rajeev
Mahajan, Raman
Sharma, Meenakshi
and
Kaur, Sukhbir
2009.
Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis.
Parasitology International,
Vol. 58,
Issue. 4,
p.
359.
Kumari, Shraddha
Samant, Mukesh
Khare, Prashant
Misra, Pragya
Dutta, Sujoy
Kolli, Bala Krishna
Sharma, Sharad
Chang, Kwang Poo
and
Dube, Anuradha
2009.
Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.
European Journal of Immunology,
Vol. 39,
Issue. 1,
p.
178.
Bhowmick, Swati
Mazumdar, Tuhina
Sinha, Roma
and
Ali, Nahid
2010.
Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.
Journal of Controlled Release,
Vol. 141,
Issue. 2,
p.
199.